Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
About this item
Full title
Author / Creator
Zhong, Lei , Li, Yueshan , Xiong, Liang , Wang, Wenjing , Wu, Ming , Yuan, Ting , Yang, Wei , Tian, Chenyu , Miao, Zhuang , Wang, Tianqi and Yang, Shengyong
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since the first tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration (FDA) in 2001, an increasing number of small-molecule targeted drug...
Alternative Titles
Full title
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ab15cc47e87e4d4bbca67fce8a8617f4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab15cc47e87e4d4bbca67fce8a8617f4
Other Identifiers
ISSN
2059-3635,2095-9907
E-ISSN
2059-3635
DOI
10.1038/s41392-021-00572-w
